-
Symbol
-
HEPA on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
576,482 shares
-
Security Ownership %
-
4.9%
Anson Funds Management LP ownership in Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA)
14 Aug 2025 - Anson Funds Management LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 576,482 shares of Hepion Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (HEPA).
This represents 4.9% ownership of the company.
In their previous filing dated 15 May 2025, Anson Funds Management LP had reported owning 595,719 shares, indicating a decrease of +3.2%.
.